Ca. Sharp et al., PLASMA ALUMINUM IN A REFERENCE POPULATION - THE EFFECTS OF ANTACID CONSUMPTION AND ITS INFLUENCE ON BIOCHEMICAL INDEXES OF BONE-FORMATION, European journal of clinical investigation, 23(9), 1993, pp. 554-560
Aluminium is involved in the etiology of several complications of chro
nic renal failure and has been firmly established as having toxic effe
cts on bone tissue. We have measured plasma aluminium together with se
rum osteocalcin, procollagen I C-terminal peptide and total alkaline p
hosphatase activity in healthy subjects and in a group of subjects who
consumed aluminium-containing and non-aluminium containing antacid pr
eparations, with normal renal function. Age-related healthy reference
ranges for plasma aluminium are presented and the effects of chronic a
ntacid consumption on plasma aluminium and biochemical markers of bone
formation investigated. In 172 healthy subjects the mean plasma alumi
nium concentration was 4.4+/-2.9 mug L-1, men having a significantly g
reater circulating aluminium load than women (5.4+/-2.8 mug L-1 vs. 4.
0+/-2.8 mug L-1 respectively (P=0.0039)). Older men were found to have
significantly higher plasma aluminium levels than younger men. Increa
sed plasma aluminium was seen in subjects taking antacids although thi
s was not associated with significant changes in most indices of bone
formation.